Josh Gottheimer's LLY trades

  • The latest LLY trade was a sale on May 13, 2025, when LLY closed at $746.06. It closed at $1182.62 on Oct 12, 2026 (+59%).

Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.

Josh Gottheimer reported 13 LLY transactions in 6 filings with the House Clerk for 2025–2026: 1 purchase and 12 sales of Eli Lilly and Company, with trade dates from Dec 9, 2024 to May 13, 2025. The median gap between trade date and filing date is 33 days, and every trade was reported within 45 days.

Transactions
13
Buys / sells
1 / 12
Disclosed range
$13K – $195K
Last filed
2025-06-11

LLY transactions reported by Josh Gottheimer

13 of 13 rows
TypeOwner
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-06-11
#20030462
Eli Lilly and Company Common Stock
LLY
PurchaseJoint$1,001 - $15,0002025-06-11
#20030462
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-05-14
#20030338
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-04-10
#20029083
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-03-06
#20027901
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-02-10
#20026732
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533
Eli Lilly and Company Common Stock
LLY
SaleJoint$1,001 - $15,0002025-01-14
#20026533

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

How long disclosure took

Days from trade date to filing date for 13 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.

0–15 days
1
16–30 days
3
31–45 days
9
Over 45 days
0
Median / longest
33d / 41d

Source documents

6 House Clerk periodic transaction reports, newest first. Each link opens the official filing.

What Josh Gottheimer's LLY filings don’t tell you

A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.

To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $39 a month.

Read the full research

Josh Gottheimer and LLY: questions

Did Josh Gottheimer buy or sell LLY?

House Clerk filings for 2025 and 2026 show 1 purchase and 12 sales of Eli Lilly and Company (LLY) reported by Josh Gottheimer, between 2024-12-09 and 2025-05-13. Reported owner: Joint.

How much LLY did Josh Gottheimer trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $13K – $195K across 13 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last LLY filing by Josh Gottheimer?

The most recent filing that includes a LLY trade was filed on 2025-06-11. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Eli Lilly and Company. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Josh Gottheimer LLY disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.

$39/mo or $249/yr · cancel future renewals anytime · sources included